Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Preventis is a German medical technology company specializing in point-of-care diagnostics and telemedicine solutions. The company is best known for its QuantOn technology, which enables the quantitative evaluation of rapid diagnostic tests using a smartphone app. Their product portfolio focuses on gastrointestinal health, including calprotectin monitoring for inflammatory bowel disease, as well as screenings for vitamin D levels and colorectal cancer. By bridging the gap between traditional laboratory testing and home-based monitoring, Preventis facilitates proactive health management and chronic disease monitoring. The company serves both healthcare professionals and consumers through its innovative digital health platforms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Preventis.